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Abstract
While skin cancer is the most diagnosed form of cancer in men
and women, with more cases diagnosed each year than all other
cancers combined, sufficiently early diagnosis results in very good
prognosis and as such makes early detection crucial. While ra-
diomics have shown considerable promise as a powerful diagnostic
tool for significantly improving oncological diagnostic accuracy and
efficiency, current radiomics-driven methods have largely rely on
pre-defined, hand-crafted quantitative features, which can greatly
limit the ability to fully characterize unique cancer phenotype that
distinguish it from healthy tissue. Recently, the notion of discovery
radiomics was introduced, where a large amount of custom, quan-
titative radiomic features are directly discovered from the wealth of
readily available medical imaging data. In this study, we present
a novel discovery radiomics framework for skin cancer detection,
where we leverage novel deep multi-column radiomic sequencers
for high-throughput discovery and extraction of a large amount of
custom radiomic features tailored for characterizing unique skin
cancer tissue phenotype. The discovered radiomic sequencer was
tested against 9,152 biopsy-proven clinical images comprising of
different skin cancers such as melanoma and basal cell carcinoma,
and demonstrated sensitivity and specificity of 91% and 75%, re-
spectively, thus achieving dermatologist-level performance and
hence can be a powerful tool for assisting general practitioners
and dermatologists alike in improving the efficiency, consistency,
and accuracy of skin cancer diagnosis.
1 Introduction
Skin cancer is the most diagnosed form of cancer, with more new
cases of skin cancer diagnosed each year than all other forms of
cancers combined [14]. Furthermore, the annual cost for the treat-
ment of skin cancer in the U.S. is estimated at $8.1 billion [7]. Fortu-
nately, there are high chance of prognosis for various forms of skin
cancer given sufficiently early diagnosis, making early skin cancer
screening and detection crucial for patient recovery. A powerful di-
agnostic tool that has shown considerable promise for ushering in
a new era of imaging-driven quantitative personalized cancer de-
cision support and management is the notion of radiomics [10],
which involves the high-throughput extraction and analysis of a
large number of quantitative features to characterize cancer tissue
traits to improve oncological diagnostic efficiency, consistency, and
accuracy.
Despite its considerable promise [11, 12], current radiomics-
driven methods have largely relied on predefined, hand-crafted
imaging-based feature models based on human notions of inten-
sity, texture, and shape, and as such can greatly limit the ability to
fully characterize unique cancer phenotype that distinguish it from
healthy tissue. Recently, to alleviate the limitations of radiomics,
the notion of discovery radiomics was introduced [8, 9, 13, 16],
where a large amount of custom, quantitative radiomic features
are directly discovered from the wealth of readily available medi-
cal imaging data.
In this study, we present a novel discovery radiomics frame-
work for skin cancer detection, where we leverage novel multi-
column deep radiomic sequencers for high-throughput discovery
and extraction of a large amount of custom radiomic features tai-
lored for characterizing unique skin cancer tissue phenotype. Deep
neural networks have shown that they can learn effective and ac-
curate feature extraction framework via convolutional layers. This
type of operations decrease the human model bias since they are
trained as an end-to-end systems. Due to this fact, the features ex-
tracted from deep neural networks (particularly convolutional neu-
ral networks) have showing promising results in different applica-
tions such as object classification [1, 2], object segmentation and
detection [3] and super-resolution [4].
The proposed framework has considerable potential for discov-
ering a large amount of quantitative biomarkers beyond what clini-
cians can visually identify, thus making it a powerful tool for assist-
ing general practitioners and dermatologists alike in improving the
efficiency, consistency, and accuracy of skin cancer diagnosis.
This paper is organized as follows; In the next section the no-
tion of discovery radiomics and the deep multi-column neural net-
work for the purpose of generating discovery radiomic sequences
is explained. Then the Results are demonstrated and the conclu-
sion will be drawn at the end.
2 Methodology
The proposed discovery radiomics framework for skin cancer de-
tection can be described as follows (see Figure 1). Given a wealth
of past clinical images and corresponding biopsy-verified diagnos-
tic information from a skin imaging data archive, the radiomic se-
quencer discovery process discovers a radiomic sequencer that
can perform high-throughput extraction of radiomic sequences com-
prising of a large amount of highly customized, quantitative fea-
tures tailored for characterizing unique skin cancer traits that are
particularly effective at differentiating between malignant and be-
nign skin lesions. The discovered radiomic sequencer can then
be applied to clinical images of a new patient to extract the corre-
sponding dermatological radiomic sequence for skin cancer screen-
ing and diagnosis purposes.
In this study, the radiomic sequencer being proposed in the dis-
covery radiomics framework is a novel deep multi-column radiomic
sequencer, inspired by the work of Ciresan et al. [6]. More specif-
ically, the proposed deep multi-column radiomic sequencer splits
information into multiple, parallel columns so that parallel streams
of increasingly more abstract skin cancer traits are discovered and
modeled based on a wealth of skin imaging data before being
merged into a single representation, thus allowing for improved
and more complete characterization of the complex physiological
characteristics of skin cancer.
The underlying architecture of the proposed deep multi-column
radiomic sequencer being discovered is shown in Figure 2. In
this architecture, low-level skin tissue characteristics are modeled
in the lower convolutional layers. However the layers are divided
into multiple parallel columns of deep convolutional layers that de-
compose into unique mid- to high-level skin tissue characteristics.
These parallel columns of deep convolutional layers are then merged
via a fully-connected layer to produce a final radiomic sequence for
the skin lesion being analyzed.
In this study, taking inspiration from [1], the realization of the
deep multi-column network architecture consists of two columns,
with each column consisting of five convolutional layers. The ex-
amined network architecture in this study is the combination of
two-column networks with each column consisting of 5 convolu-
tional layers. The number of convolutional filters are increased and
the size of the convolutional filters are decreased as we go deeper
to improve the modeling performance of the deep, multi-column ra-
diomic sequencer. This led the proposed radiomic sequencer to
possess the following architectural configuration for each column:
five convolutional layers with 96@ 7× 7 filters, 256@ 5× 5 filters,
384@ 3× 3 filters, 384@ 3× 3 filters, 256@ 5× 5 filters, and one
fully connected layer with 8192 neurons. The output of two columns
are combined together to produce the final radiomic sequence.
2.1 Results and Discussion
In this study, the discovered deep multi-column radiomic sequencer
was tested against 9,152 biopsy-proven clinical images extracted
from ISIC 2017 Challenge dataset [17] (see Figure 3), with the
malignant cases comprising of 90% melanoma cases and 10%
basal cell carcinoma cases. Sequencer validation was performed
by splitting the clinical images into 10% training (473 randomly se-
lected samples for each class label) and 90% testing. The testing
dataset comprises of 8,049 benign and 157 malignant cases. To
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Fig. 1: Overview of the proposed discovery radiomics framework for skin cancer detection. A custom radiomic sequencer is discovered
via past skin imaging data; for new patients, radiomic sequences of custom radiomic features are generated for skin cancer quantifi-
cation and analysis. In this study, we leverage a deep multi-column radiomic sequencer to characterize and model unique skin cancer
phenotype.
quantitatively evaluate the efficacy of the discovery radiomic se-
quencer for cancer detection, the radiomic sequences produced
using the sequencer are then fed into a fully-connected feed-foward
neural network with two fully-connected layers and a softmax layer.
The efficacy of the proposed discovery radiomics framework is
examined quantitatively using two performance metrics: i) sensitiv-
ity, and ii) specificity; where
sensitivity=
true positive
positive
(1)
specificity=
true negative
negative
. (2)
where true positive is the number of malignant cases which are
classified correctly by the proposed approach and true negative is
the number of benign cases classified as negative by the proposed
approach.
Experimental results show that the proposed radiomic sequencer
achieved sensitivity and specificity of 91% and 75%, respectively.
As a point of reference, in the study by Wells et al. [15], it was
found that the dermatologists in the study had a sensitivity and
specificity of 80% and 43%, respectively for melanoma screen-
ing, while MelaFind, a non-invasive light-based tool for skin cancer
screening, had a sensitivity and specificity of 96% and 8%, respec-
tively. Furthermore, in a study by Esteva et al. [5], it was found
that using an Inception v3 convolutional neural network trained for
distinguishing between benign skin lesions, malignant lesions, and
non-neoplastic lesions achieved an accuracy of 72.1 ± 0.9% on
dermatologist-labeled clinical images. As such, these experimental
results show that the proposed radiomic sequencer for skin cancer
detection is able to achieve dermatologist-level performance and
hence can be a powerful tool for assisting general practitioners
and dermatologists alike in improving the efficiency, consistency,
and accuracy of skin cancer diagnosis.
3 Conclusion
In this paper we proposed a new discovery radiomics approach for
the purpose of skin cancer modeling and classification. A deep
multi-column radiomic sequencer is proposed and discovered for
high-throughput discovery and extraction of a large amount of cus-
tom radiomic features tailored for characterizing unique skin cancer
tissue phenotype. The deep multi-column architecture used in the
proposed radiomic sequencer can significantly boost the modeling
power of the sequencer. The discovered deep multi-column ra-
diomic sequencer can then be applied to clinical images of a new
patient to extract the corresponding dermatological radiomic se-
quence for skin cancer screening and diagnosis purposes.
The proposed framework is examined on ISIC skin cancer chal-
lenge, with the deep multi-column radiomic sequencer discovered
using a small balanced dataset of malignant and benign cases
where only 473 cases were utilized for each class label. Quanti-
tative evaluation of the discovered radiomic sequencer was then
performed using an unbalanced dataset with 8,049 benign cases
and 157 malignant cases. Experimental results demonstrated that
the proposed discovery radiomics approach for skin cancer model-
ing and classification is able to achieving sensitivity and specificity
of 91% and 75%, respectively. These promising results show the
applicability and modeling power of the proposed approach and
illustrates that it can be a powerful tool for assisting general practi-
tioners and dermatologists alike in improving the efficiency, consis-
tency, and accuracy of skin cancer diagnosis.
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